WILLIAM MAST: Open Payments
NPI 1659089811 · GREENVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,058 in 127 payments from 13 companies in 2025. Trend: 2023 $1,924 · 2024 $4,510 · 2025 $4,058
Food & beverage: $2,935Consulting: $800Education: $323
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 7 | $1,072 |
| ABBVIE INC. | 26 | $509 |
| Janssen Biotech, Inc. | 12 | $493 |
| Lilly USA, LLC | 14 | $393 |
| Regeneron Healthcare Solutions, Inc. | 13 | $384 |
| UCB, Inc. | 11 | $344 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $245 |
| GENZYME CORPORATION | 14 | $219 |
| Eli Lilly and Company | 1 | $99 |
| Organon LLC | 9 | $92 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, Bimzelx, TALTZ, ANZUPGO, RINVOQ, EBGLYSS.
Industry payments across TX — which companies pay providers there.
